Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
27.88-0.65 (-2.28%)
At close: 04:00PM EDT
27.88 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close28.53
Open28.64
Bid11.06 x 800
Ask29.00 x 1000
Day's Range27.45 - 28.94
52 Week Range23.87 - 51.60
Volume148,885
Avg. Volume167,106
Market Cap369.452M
Beta (5Y Monthly)0.92
PE Ratio (TTM)10.03
EPS (TTM)2.78
Earnings DateMay 08, 2023 - May 12, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
6% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for EGRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Eagle Pharmaceuticals, Inc.
    EGRX: Lowering target price to $26.00EAGLE PHARMACEUTICALS INC has an Investment Rating of SELL; a target price of $26.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement